Nitraatide

Nitraatide is a synthetic peptide hormone that is structurally similar to natriuretic peptides, which are naturally occurring hormones in the body. It is primarily used in the treatment of heart failure, a condition characterized by the heart's inability to pump blood effectively. Nitraatide works by mimicking the action of natriuretic peptides, which help to regulate blood pressure and fluid balance in the body. By doing so, it helps to reduce the workload on the heart and improve its efficiency.

The drug was developed by the pharmaceutical company Actelion Pharmaceuticals and was approved by the U.S. Food and Drug Administration (FDA) in 2015. It is administered via subcutaneous injection, typically once daily. Nitraatide has been shown to improve symptoms of heart failure, such as shortness of breath and fatigue, and to reduce the risk of hospitalization for heart failure.

However, like any medication, nitraatide has potential side effects. Common side effects may include headache, dizziness, and injection site reactions. Serious side effects are rare but can include allergic reactions and severe hypotension (low blood pressure). As with any medication, it is important for patients to discuss the potential benefits and risks with their healthcare provider before starting treatment with nitraatide.